Kela piloting interest-free medicine cost credit – securing the continuity of prescription medicine use a priority
7.10.2025 09:04:16 EEST | Kela/FPA | Press release
In autumn 2025, Kela launches a pilot study to test a new type of credit Kela can grant for medicine costs. During the pilot study, low-income customers can apply for interest-free credit from Kela to help them pay high medicine costs.
Starting from the end of October 2025, low-income customers will have the opportunity to get a loan from Kela in the form of a credit for medicine costs (lääkeluotto, medicine cost credit) to pay the annual maximum limit on out-of-pocket medicine costs (vuosiomavastuu, lääkekatto, annual out-of-pocket maximum). The aim is to ensure that customers can get the prescription medication they need when they need it and that they do not stop taking their medication due to financial constraints. Kela grants the credit as part of a pilot study that begins on 27 October 2025.
Medicine cost credit helps with high prescription medicine costs
In 2025, the annual out-of-pocket maximum is EUR 633.17. Medicine cost credit is intended for low-income customers who do not qualify for social assistance and who reach the annual out-of-pocket maximum either with one purchase or within one calendar month. The amount of credit Kela can grant is up to the amount of the full annual out-of-pocket maximum.
The customer will pay the medicine cost credit back to Kela over the span of 12 months. Kela does not charge any interest for the credit. In practice, the medicine cost credit will help lighten the financial burden on the customer by spreading the costs of prescription medicine over several months instead of the customer having to pay a large sum in one go or within a short period of time.
In 2024, a total of 7.9% of all customers who were paid reimbursements for medicine costs reached the annual out-of-pocket maximum. Altogether 3% of those customers reached the annual out-of-pocket maximum with one transaction, and 80% of them bought only one kind of prescription medication. In addition, 93% of all customers who reached the annual out-of-pocket maximum with one transaction in 2024 also did so in 2023. This suggests that the same customers reach the annual out-of-pocket maximum year after year.
Apply for the credit before you buy the medication
You must apply for the medicine cost credit in the OmaKela e-service (available in Finnish and Swedish only) or by visiting a Kela service point before you buy the prescription medication you need. You must send us a document listing the necessary medication you plan to buy together with your application. For example, you can submit patient instructions issued by a doctor or a prescription summary you can print out from MyKanta. Please also tell us the month in which you need to buy the medication in your application. The earliest that you can submit an application for the credit is 2 months before you buy your medication. If you are the parent or guardian of a child, you can also apply for the medicine cost credit to help pay for the child’s annual out-of-pocket maximum.
Kela will process your application and assess if you will reach the annual out-of-pocket maximum. Kela uses the prescriptions you send us with your application to make the assessment.
If you qualify for the medicine cost credit, Kela will transfer it to your bank account. You must pay the credit back to Kela within one year.
The pilot study as a source of data and support for decision-making
The pilot study is based on the Government Programme of Prime Minister Petteri Orpo’s Government, which seeks to, for example, divide the annual maximum limit on out-of-pocket medicine costs into parts and transfer the social lending system under Kela’s administration. Kela was granted EUR 2.5 million for the pilot study in the amendments made to the national budget in 2025.
Kela estimates that it will grant the medicine cost credit approximately 5,000 times during the pilot study. The aim of the pilot study is to produce data on what kind of resources the provision of this kind of credit will require in terms of Kela’s information systems and customer service. During the pilot study, Kela will also conduct a separate study to assess how the pilot study affects the rates of prescription medicine use and the customer experience.
Read more
Credit for medicine costs (kela.fi)
Kela’s medicine cost credit can help with high medicine costs (brochure, PDF)
Contacts
Tomi StåhlHead of the Centre of ExpertiseKela
Tel:040 539 7162firstname.lastname@kela.fiPetri HasselLegal CounselKela
Tel:050 438 3386firstname.lastname@kela.fiKela's Communications UnitFor media enquiries, please contact us between 9:00 and 16:00, Monday to Friday. This number can be used for interview requests, which we will be happy to forward to an appropriate source at Kela. You can also submit interview requests by email.
Tel:+358 20 634 7745viestinta@kela.fiAlternative languages
Subscribe to releases from Kela/FPA
Subscribe to all the latest releases from Kela/FPA by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Kela/FPA
FPA kartlägger erfarenheter av att kombinera inkomster och förmåner7.9.2026 08:56:29 EEST | Pressmeddelande
Med hjälp av en enkät kartlägger FPA erfarenheter av att kombinera arbete, inkomster och förmåner från FPA. Vi använder enkätens svar för att förbättra våra tjänster och göra det lättare att sköta FPA-ärenden. Enkäten kan besvaras i FPA:s kundgemenskap fram till 13.9.2026.
Kela selvittää kokemuksia tulojen ja tukien yhteensovittamisesta7.9.2026 08:56:29 EEST | Tiedote
Läs meddelandet på svenska (fpa.fi). Pressrelease in English (kela.fi). Kela kartoittaa kyselyllä kokemuksia työnteon, tulojen ja Kelan tukien yhteensovittamisesta. Kyselyn tuloksia hyödynnetään palvelujen ja asioinnin kehittämisessä. Kysely on avoinna Kelan asiakasyhteisössä 13.9.2026 saakka.
Kela asks for customers’ experiences on how income and benefits fit together7.9.2026 08:56:29 EEST | Press release
Kela is conducting a survey to find out how customers combine work, income and Kela benefits. The results of the survey will be used to develop Kela’s services and how they can be accessed. Members of Kela’s Customer Community can answer the survey until 13 September 2026.
Mer än 80 % av FPA:s brev skickas elektroniskt – kom ihåg att kontrollera Suomi.fi-meddelanden3.9.2026 10:06:52 EEST | Pressmeddelande
Mer än 80 % av FPA:s brev skickas numera endast elektroniskt. Redan 95 % av alla kunder får aviseringar via Suomi.fi-meddelanden om att de har fått post i MittFPA. Det är viktigt att man kontrollerar meddelanden i Suomi.fi, så att man inte missar ett nytt beslut eller brev. FPA skickar fortfarande papperspost till kunder som inte använder MittFPA eller som har valt att kommunicera per post.
Kelan kirjeistä yli 80 % toimitetaan sähköisesti – muista tarkistaa Suomi.fi-viestisi3.9.2026 10:06:52 EEST | Tiedote
Läs meddelandet på svenska (fpa.fi). Pressrelease in English (kela.fi). Yli 80 % Kelan kirjeistä toimitetaan nykyisin vain sähköisesti. Jo 95 % asiakkaista saa ilmoituksen OmaKelaan saapuneesta postista Suomi.fi-viestinä. Asiakkaan on tärkeää tarkistaa Suomi.fi-viestit, jotta tieto uudesta päätöksestä tai kirjeestä ei jää huomaamatta. Paperipostia saavat edelleen asiakkaat, jotka eivät käytä OmaKelaa tai ovat valinneet paperisen asioinnin.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom